Evidence map›Paper›PMID 37069139›Full record

ArticleSignal transduction and targeted therapy2023

Alterations of the oral and gut mycobiome and cytokines during long-term follow-up of COVID-19 convalescents.

Zhigang Ren, Shanshuo Liu, Qiong Wang, Benchen Rao, Zhaohai Zeng, Yakun Xu, Haiyu Wang, Hong Luo, Jianjun Gou, Zujiang Yu

Abstract readLetter
In one paragraph

Article in Signal transduction and targeted therapy, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Gut Mycobiome Changes During COVID-19 Disease.Journal of fungi (Basel, Switzerland) · 2025
    Article
  4. Special Issue: Gut Microbiota in Disease and Health 2.0.International journal of molecular sciences · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Zhigang Ren *Department of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.ORCID 0000-0003-0798-3444
Shanshuo Liu *Department of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Qiong Wang *Health Management Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Benchen RaoDepartment of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Zhaohai ZengDepartment of Infectious Diseases, Guangshan County People's Hospital, Guangshan County, Xinyang, 465450, Henan, China.
Yakun XuHealth Management Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Haiyu WangDepartment of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China.
Hong LuoDepartment of Infectious Diseases, Guangshan County People's Hospital, Guangshan County, Xinyang, 465450, Henan, China.
Jianjun GouHealth Management Center, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. goujun64@sohu.com.
Zujiang YuDepartment of Infectious Diseases, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. johnyuem@zzu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Gastrointestinal MicrobiomeMycobiomeCytokinesFollow-Up StudiesHumansCytokines

Identifiers

PMID37069139
PMCPMC10106887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.